IAG:ASXInsurance Australia Group Ltd Analysis
Data as of 2026-06-12 - not real-time
A$8.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Insurance Australia Group is trading at AUD 8, comfortably above its 20‑day SMA of 7.79 and its 200‑day SMA of 7.70, while the MACD line sits in bullish territory (0.065 above the signal). The RSI of 62 indicates modest upward momentum but warns of potential over‑extension. Valuation metrics show a trailing P/E of 17.4 versus an industry average of 16.9, and a DCF‑derived fair value of 5.58, implying the stock is currently priced above intrinsic estimates. The dividend yield of 3.88 % with a payout ratio near 68 % remains attractive, though free cash flow is negative, raising modest sustainability concerns. Revenue growth of 10.3 % and operating margins near 9.4 % underscore solid earnings momentum, supported by rising insurance premiums noted in recent investor‑day commentary. However, a beta of 0.12 and 30‑day volatility of 28 % suggest the stock is relatively insulated from market swings but still subject to sector‑specific shocks.
Given the bullish technical setup, strong dividend profile, and steady earnings growth, the near‑term outlook favors a cautious accumulation strategy. The modest upside of 4 % above current levels is limited, and the over‑valued DCF estimate tempers enthusiasm for aggressive buying. Medium‑ to long‑term investors should monitor cash‑flow dynamics and regulatory developments, as these will dictate whether the premium valuation can be justified. Overall, the stock presents a balanced risk‑return case, with the dividend offering a buffer against valuation headwinds.
Given the bullish technical setup, strong dividend profile, and steady earnings growth, the near‑term outlook favors a cautious accumulation strategy. The modest upside of 4 % above current levels is limited, and the over‑valued DCF estimate tempers enthusiasm for aggressive buying. Medium‑ to long‑term investors should monitor cash‑flow dynamics and regulatory developments, as these will dictate whether the premium valuation can be justified. Overall, the stock presents a balanced risk‑return case, with the dividend offering a buffer against valuation headwinds.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD histogram indicating upward momentum
- Price near technical support at 7.44 with increasing volume
- Attractive dividend yield of 3.88% providing immediate income
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stock trading above DCF fair value, limiting upside potential
- Sustained revenue growth of 10% driven by premium increases
- Stable dividend payout but negative free cash flow adds caution
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Long‑term dividend sustainability linked to operating cash flow
- Regulatory and climate‑related risks inherent to the insurance sector
- Valuation premium requiring continued earnings acceleration
Key Metrics & Analysis
Financial Health
Revenue Growth10.30%
Profit Margin5.95%
P/E Ratio17.4
ROE15.74%
ROA4.59%
Debt/Equity41.71
P/B Ratio2.6
Op. Cash FlowA$1.1B
Free Cash FlowA$-396624992
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI62.0
SupportA$7.43
ResistanceA$8.26
MA 20A$7.79
MA 50A$7.56
MA 200A$7.70
MACDBullish
VolumeIncreasing
Fear & Greed Index88.39
Valuation
Fair ValueA$5.58
Target PriceA$8.32
Upside/Downside4.00%
GradeOvervalued
TypeBlend
Dividend Yield3.88%
Risk Assessment
Beta0.12
Volatility28.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.